Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 137.00 | |
5 mg | 5 days | $ 235.00 | |
10 mg | 5 days | $ 392.00 |
Description | EPZ020411 is a specific and effective inhibitor of PRMT6 (IC50=10 nM). |
Targets&IC50 | PRMT6:10 nM |
In vitro | In PRMT6-overexpressing cells, EPZ020411 does-dependently inhibits H3R2 methylation. |
In vivo | in vivo: EPZ020411 shows good bioavailability following subcutaneous (SC) dosing in rats making it a suitable tool for in vivo studies. |
Synonyms | EPZ020411 2HCl |
Molecular Weight | 442.6 |
Formula | C25H38N4O3 |
CAS No. | 1700663-41-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EPZ020411 1700663-41-7 Chromatin/Epigenetic Histone Methyltransferase Apoptosis cochleae EPZ020411 2HCl tool compound cancer EPZ 020411 inhibit Inhibitor A375 oncology EPZ-020411 inhibitor